Biofrontera Inc. (BFRI) Financials

BFRI Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 27.9 million 23.1 million
2023-09-30 34.1 million 33.1 million
2023-06-30 36.9 million 29.7 million
2023-03-31 42.0 million 25.2 million

BFRI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -8.9 million 228000
2023-09-30 -2.0 million 207000
2023-06-30 -10.3 million 259000
2023-03-31 -3.7 million 351000

BFRI Net Income

No data available :(

BFRI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.4 million - 1.5 million
2023-09-30 6.8 million - 1.1 million
2023-06-30 10.4 million - 1.1 million
2023-03-31 21.1 million - 1.2 million

BFRI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.1 million
2023-09-30 1.4 million
2023-06-30 1.4 million
2023-03-31 1.3 million

BFRI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 9000 33000 9.1 million -295000
2023-09-30 - 33000 8.7 million -74000
2023-06-30 - 11000 11.5 million -
2023-03-31 14000 - 9.8 million -

BFRI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 10.6 million 5.7 million
2023-09-30 8.9 million 4.5 million
2023-06-30 5.8 million 2.9 million
2023-03-31 8.7 million 4.6 million

BFRI

Price: $1.79

52 week price:
0.61
13.42

Earnings Per Share: -13.02 USD

P/E Ratio: -0.03

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 345400

Market Capitalization: 9.3 million

Links: